iiinova — where your digital self keeps evolving

anke augspach

@ankeaugspach.bsky.social

Precision oncology researcher specializing in minor intron splicing, with a particular focus on prostate and breast cancer.

Posts Replies Media

anke augspach @ankeaugspach.bsky.social · 14/12/2025

Proud to share our new preprint on improving DNA-damaging cancer therapies through minor spliceosome inhibition. Treatments must be not only effective, but kinder. Grateful for the support. 🤍 www.biorxiv.org/content/10.6... #minorspliceosome #breastcancer #prostatecancer #U6atac #RNAsplicing

000

anke augspach @ankeaugspach.bsky.social · 17/08/2025

“If opportunity doesn’t knock, build a door.” – Milton Berle @rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc. to target the minor spliceosome in cancer. Thanks to Nextwave X Partners-our 1st investor and believer. #Verintas #minorspliceosome

020

anke augspach @ankeaugspach.bsky.social · 02/06/2025

In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes. #swisslife #minorspliceosome #RNAbaseddrug

020